| CD100/Plexin-B1 interactions sustain proliferation and survival of normal and leukemic CD5+ B lymphocytes L Granziero, P Circosta, C Scielzo, E Frisaldi, S Stella, M Geuna, ... Blood, The Journal of the American Society of Hematology 101 (5), 1962-1969, 2003 | 196 | 2003 |
| Pain and the context E Carlino, E Frisaldi, F Benedetti Nature Reviews Rheumatology 10 (6), 348-355, 2014 | 148 | 2014 |
| Teaching neurons to respond to placebos F Benedetti, E Frisaldi, E Carlino, L Giudetti, A Pampallona, M Zibetti, ... The Journal of physiology 594 (19), 5647-5660, 2016 | 99 | 2016 |
| Placebo and nocebo effects: a complex interplay between psychological factors and neurochemical networks E Frisaldi, A Piedimonte, F Benedetti American Journal of Clinical Hypnosis 57 (3), 267-284, 2015 | 99 | 2015 |
| Role of explicit verbal information in conditioned analgesia E Carlino, DME Torta, A Piedimonte, E Frisaldi, S Vighetti, F Benedetti European journal of pain 19 (4), 546-553, 2015 | 60 | 2015 |
| Why we should assess patients’ expectations in clinical trials E Frisaldi, A Shaibani, F Benedetti Pain and Therapy 6, 107-110, 2017 | 59 | 2017 |
| Characterization of the thalamic–subthalamic circuit involved in the placebo response through single-neuron recording in Parkinson patients E Frisaldi, E Carlino, M Lanotte, L Lopiano, F Benedetti Cortex 60, 3-9, 2014 | 56 | 2014 |
| Placebo response in pain, fatigue, and performance: possible implications for neuromuscular disorders A Shaibani, E Frisaldi, F Benedetti Muscle & nerve 56 (3), 358-367, 2017 | 45 | 2017 |
| Understanding the mechanisms of placebo and nocebo effects E Frisaldi, A Shaibani, F Benedetti Swiss Medical Weekly 150 (3536), w20340-w20340, 2020 | 40 | 2020 |
| The effects of placebos and nocebos on physical performance E Carlino, A Piedimonte, E Frisaldi Placebo, 149-157, 2014 | 40 | 2014 |
| The placebo effect on bradykinesia in Parkinson's disease with and without prior drug conditioning E Frisaldi, E Carlino, M Zibetti, D Barbiani, F Dematteis, M Lanotte, ... Movement Disorders 32 (10), 1474-1478, 2017 | 35 | 2017 |
| Nocebo and the contribution of psychosocial factors to the generation of pain F Benedetti, E Frisaldi, D Barbiani, E Camerone, A Shaibani Journal of Neural Transmission 127, 687-696, 2020 | 33 | 2020 |
| How do placebos work? F Benedetti, A Piedimonte, E Frisaldi European Journal of Psychotraumatology 9 (sup3), 1533370, 2018 | 31 | 2018 |
| Thirty years of neuroscientific investigation of placebo and nocebo: the interesting, the good, and the bad F Benedetti, E Frisaldi, A Shaibani Annual Review of Pharmacology and Toxicology 62 (1), 323-340, 2022 | 29 | 2022 |
| Effectiveness of a dance-physiotherapy combined intervention in Parkinson’s disease: a randomized controlled pilot trial E Frisaldi, P Bottino, M Fabbri, M Trucco, A De Ceglia, N Esposito, ... Neurological Sciences 42 (12), 5045-5053, 2021 | 27 | 2021 |
| Placebo F Benedetti, P Enck, E Frisaldi, M Schedlowski Springer, 2014 | 18 | 2014 |
| Creating placebo responders and nonresponders in the laboratory: boons and banes F Benedetti, E Frisaldi Pain Management 4 (3), 165-167, 2014 | 18 | 2014 |
| Prognostic values of soluble CD30 and CD30 gene polymorphisms in heart transplantation E Frisaldi, R Conca, P Magistroni, ME Fasano, G Mazzola, F Patanè, ... Transplantation 81 (8), 1153-1156, 2006 | 17 | 2006 |
| Placebo responders and nonresponders: what’s new? E Frisaldi, A Shaibani, F Benedetti Pain management 8 (6), 405-408, 2018 | 16 | 2018 |
| The placebo response in myasthenia gravis assessed by quantitative myasthenia gravis score: a meta‐analysis E Frisaldi, A Shaibani, J Vollert, B Ferrero, R Carrino, HD Ibraheem, ... Muscle & Nerve 59 (6), 671-678, 2019 | 10 | 2019 |
